Published in Aliment Pharmacol Ther on September 01, 2007
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial. Dig Dis Sci (2012) 1.47
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol (2013) 1.41
Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol (2010) 1.38
Novel therapies for coeliac disease. J Intern Med (2011) 1.17
The present and the future in the diagnosis and management of celiac disease. Gastroenterol Rep (Oxf) (2014) 1.06
Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia (2010) 1.06
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol (2012) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas. Int J Pediatr Endocrinol (2010) 1.04
Recent advances in celiac disease. World J Gastroenterol (2011) 1.03
Non-systemic drugs: a critical review. Curr Pharm Des (2012) 1.02
Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci (2012) 1.00
Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol (2012) 0.98
Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol (2011) 0.97
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers (2013) 0.91
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol (2008) 0.89
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol (2016) 0.87
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology (2015) 0.86
Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials. Gastroenterol Rep (Oxf) (2015) 0.85
Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis. Clin Dev Immunol (2012) 0.85
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
Type 1 diabetes mellitus and gluten induced disorders. Gastroenterol Hepatol Bed Bench (2014) 0.83
Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect. Dig Dis Sci (2011) 0.82
Novel strategies for targeting innate immune responses to influenza. Mucosal Immunol (2016) 0.81
Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. Clin Exp Immunol (2012) 0.81
Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol (2015) 0.81
Identification of gliadin-binding peptides by phage display. BMC Biotechnol (2011) 0.81
Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut (2009) 0.80
Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms. Gut Liver (2015) 0.79
New and developing therapies for celiac disease. Therap Adv Gastroenterol (2009) 0.79
Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov (2013) 0.79
Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities. Nutrients (2016) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Non-dietary methods in the treatment of celiac disease. Prz Gastroenterol (2015) 0.78
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 0.78
Current and emerging therapy for celiac disease. Front Med (Lausanne) (2014) 0.78
Novel avian single-chain fragment variable (scFv) targets dietary gluten and related natural grain prolamins, toxic entities of celiac disease. BMC Biotechnol (2015) 0.78
Non-dietary forms of treatment for adult celiac disease. World J Gastrointest Pharmacol Ther (2013) 0.78
TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway. Am J Pathol (2016) 0.78
Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? Virchows Arch (2014) 0.77
Enzymatic strategies to detoxify gluten: implications for celiac disease. Enzyme Res (2010) 0.77
New insights in celiac disease. Rambam Maimonides Med J (2012) 0.76
The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration. Dig Dis Sci (2012) 0.76
Current Status of Celiac Disease Drug Development. Am J Gastroenterol (2016) 0.75
Celiac disease: Alternatives to a gluten free diet. World J Gastrointest Pharmacol Ther (2010) 0.75
Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes. Nutrients (2017) 0.75
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci (2017) 0.75
Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol (2017) 0.75
Regulation of intestinal permeability: The role of proteases. World J Gastroenterol (2017) 0.75
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. BMC Gastroenterol (2013) 0.75
"Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A (1998) 5.02
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A (1993) 2.81
Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology (1993) 2.75
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun (1992) 2.35
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest (1991) 2.35
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A (1993) 2.28
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun (1992) 2.18
Alterations in intestinal permeability. Gut (2006) 2.17
Predicting relapse in Crohn's disease: a biopsychosocial model. Gut (2008) 2.01
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis (1993) 1.93
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci (2000) 1.78
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med (1998) 1.77
The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr (2000) 1.76
Gastrointestinal permeability in celiac disease. Gastroenterology (1997) 1.75
Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun (1992) 1.72
Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol (1998) 1.72
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis (1996) 1.69
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J Infect Dis (1995) 1.64
"On" state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology (2012) 1.59
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol (2000) 1.58
Macroamylasemia in patients with celiac disease. Am J Gastroenterol (2001) 1.54
Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol (2001) 1.54
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding. Am J Gastroenterol (2000) 1.49
Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey. Can J Gastroenterol (1999) 1.44
Multifocal corneal topographic changes with excimer laser photorefractive keratectomy. Arch Ophthalmol (1992) 1.44
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol (2009) 1.39
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol (2009) 1.39
Enterotoxicity and cytotoxicity of Vibrio parahaemolyticus thermostable direct hemolysin in in vitro systems. Infect Immun (2000) 1.39
CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect Immun (1993) 1.35
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis (1999) 1.35
IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect Immun (2000) 1.34
Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology (1996) 1.29
CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology (1995) 1.26
Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem (2001) 1.25
GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol (1998) 1.24
The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand (2006) 1.23
Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. J Clin Invest (1986) 1.22
A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet (1994) 1.20
Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria. Clin Infect Dis (1997) 1.18
Guidelines prepared by the ESPGAN Working Group on Acute Diarrhoea. Recommendations for feeding in childhood gastroenteritis. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr (1997) 1.16
Effects of berberine on basal and secretagogue-modified ion transport in the rabbit ileum in vitro. J Pediatr Gastroenterol Nutr (1988) 1.14
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol (2001) 1.13
Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease. J Pediatr Gastroenterol Nutr (2008) 1.11
Cross-talk between enteric pathogens and the intestine. Cell Microbiol (2000) 1.10
Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol (1991) 1.09
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut (2003) 1.08
Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia (2010) 1.06
Thyroxine effect on intestinal Cl-/HCO3- exchange in hypo- and hyperthyroid rats. J Endocrinol (1996) 1.04
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler (2002) 1.04
Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man. Circulation (1986) 1.03
Vibrio parahaemolyticus thermostable direct hemolysin modulates cytoskeletal organization and calcium homeostasis in intestinal cultured cells. Infect Immun (1999) 1.03
Calcium-dependent intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct hemolysin in a rabbit model. Gastroenterology (1995) 1.02
Pathogenesis of postantibiotic diarrhoea caused by Clostridium difficile: an in vitro study in the rabbit intestine. Gut (1988) 1.00
An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes (2009) 1.00
Multilamellar packing of myelin modeled by lipid-bound MBP. J Neurosci Res (2000) 0.99
Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol (1997) 0.98
Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines. FEMS Microbiol Lett (2001) 0.98
Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res (1999) 0.98
Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J Neurochem (2000) 0.97
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Neurotox Res (2009) 0.96
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia. Brain (2003) 0.96
The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol (1998) 0.96
Luminal nutrients alter tight-junction permeability in the rat jejunum: an in vivo perfusion model. Can J Physiol Pharmacol (1994) 0.96
Development of a novel rapid non-invasive screening test for coeliac disease. Gut (2000) 0.95
Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization. Microb Pathog (1999) 0.95
Assessment of enterotoxin production by Yersinia enterocolitica and identification of a novel heat-stable enterotoxin produced by a noninvasive Y. enterocolitica strain isolated from clinical material. Infect Immun (1993) 0.95
Conformation of bovine myelin basic protein purified with bound lipids. Eur Biophys J (1999) 0.95
Small angle x-ray scattering from lipid-bound myelin basic protein in solution. Biophys J (2004) 0.92
Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro. Gastroenterology (1997) 0.92
Improved method for the isolation and cultivation of human scalp dermal papilla cells. J Invest Dermatol (1992) 0.92
Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia. Leukemia (2006) 0.92
Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol (1999) 0.92
Unconjugated bilirubin and the bile from light exposed Gunn rats inhibit intestinal water and electrolyte absorption. Gut (1988) 0.92
Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist. Can J Gastroenterol (2001) 0.91
Intestinal permeability in patients with Crohn's disease. Gut (1994) 0.90
Acute necrotizing encephalopathy: a relapsing case in a European adult. J Neurol Neurosurg Psychiatry (2007) 0.90
Upper gastrointestinal toxicity of alendronate. Am J Gastroenterol (2000) 0.90
Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol (2004) 0.89
Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis (1999) 0.89
Opioid receptors on guinea-pig intestinal crypt epithelial cells. J Physiol (1996) 0.89
Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris. Infect Immun (1997) 0.89
Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens. Infect Immun (1999) 0.89
All that scallops is not celiac disease. Gastrointest Endosc (2000) 0.87
Effect of epidermal growth factor on enterocyte brush-border surface area. Am J Physiol (1993) 0.87
The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm. Neurol Sci (2013) 0.86
Kinetic characteristics and mechanisms of regulation of receptor-dependent and receptor-independent LDL transport in the liver of different animal species and humans. Am Heart J (1987) 0.86
Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats. Am J Physiol (1994) 0.86
Production of enterotoxin by Yersinia bercovieri, a recently identified Yersinia enterocolitica-like species. Infect Immun (1999) 0.85
A thermodynamic and structural study of myelin basic protein in lipid membrane models. Biophys J (2007) 0.84
Regulation of intestinal glucose transport. Can J Physiol Pharmacol (1992) 0.84
Modulation of host cell membrane fluidity: a novel mechanism for preventing bacterial adhesion. Am J Physiol (1999) 0.83
Sucrose permeability as a means of detecting diseases of the upper digestive tract. J Gastroenterol Hepatol (1998) 0.83
Specificity of zinc binding to myelin basic protein. Neurochem Res (1995) 0.83
The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol (2003) 0.83
Lipid peroxidation of the brush-border membrane: membrane physical properties and glucose transport. Am J Physiol (1993) 0.82
Transepithelial leak in Barrett's esophagus. Dig Dis Sci (2006) 0.82
Epidermal growth factor and postnatal development of intestinal transport and membrane structure. Pediatr Res (1991) 0.82